In the Matter of Lupin Ltd., a limited liability corporation; Gavis Pharmaceuticals LLC, a limited liability corporation; and Novel Laboratories, Inc., a corporation; File No. 151- 0202 #00003

Submission Number:
00003
Commenter:
K Sanders
State:
California
Initiative Name:
In the Matter of Lupin Ltd., a limited liability corporation; Gavis Pharmaceuticals LLC, a limited liability corporation; and Novel Laboratories, Inc., a corporation; File No. 151- 0202
"In the Matter of Lupin Ltd., Gavis Pharmaceuticals LLC, and Novel Laboratories, Inc.-Consent Agreement; File No. 151-0202" I am an ulcerative colitis patient who is currently taking mesalamine ER by Gavis Pharmaceuticals. Over the past year I have experienced several hospital stays due to the decreased availability of mesalamine by Gavis. Alternate brands do not provide relief and thus I am dependent on this drug. If this product is further limited from the market and the prices increased I will suffer major health effects and potential death due to complications or cancer later in life, in addition to the financial burden of the increased costs. I hope that this is strongly considered when addressing the potential merger of these pharmaceutical companies.